HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
N- succinimidyl- 3- (tri- n- butylstannyl)benzoate
Also Known As:
STBSB; m-BuATE
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
Hydrocarbons: 1713
Cyclic Hydrocarbons: 97
Aromatic Hydrocarbons: 291
Benzene Derivatives: 17
Benzoates: 426
N-succinimidyl-3-(tri-n-butylstannyl)benzoate: 1
Carboxylic Acids: 973
Carbocyclic Acids
Benzoates: 426
N-succinimidyl-3-(tri-n-butylstannyl)benzoate: 1
Organometallic Compounds: 64
Organotin Compounds: 41
Trialkyltin Compounds: 1
N-succinimidyl-3-(tri-n-butylstannyl)benzoate: 1
Related Diseases
1.
Neoplasms (Cancer)
08/15/1991 - "
We previously demonstrated that labeling the IgG2b glioma-reactive antitenascin monoclonal antibody 81C6 with 131I using N-succinimidyl-3-(tri-n-butylstannyl)benzoate (ATE) increased tumor uptake and tumor-to-normal tissue ratios and decreased deiodination compared with labeling using Iodo-Gen.
"
2.
Glioma (Gliomas)
08/15/1991 - "
We previously demonstrated that labeling the IgG2b glioma-reactive antitenascin monoclonal antibody 81C6 with 131I using N-succinimidyl-3-(tri-n-butylstannyl)benzoate (ATE) increased tumor uptake and tumor-to-normal tissue ratios and decreased deiodination compared with labeling using Iodo-Gen.
"
Related Drugs and Biologics
1.
Immunoglobulin G (IgG)
2.
Monoclonal Antibodies
3.
1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycoluril